Avantor, Inc.
Close on Oct 19, 2026
- Market cap
- $11.03B
- P/E (TTM)
- –
- Dividend yield
- –
About Avantor
Laboratory Analytical Instruments, SIC 3826
Avantor provides mission-critical products and services for research, development, and manufacturing across the biopharma, healthcare, education, government, and advanced technologies sectors. The company operates through two main segments, Laboratory Solutions and Bioscience Production, going to market via its VWR distribution channel and its proprietary manufacturing operations. Its portfolio encompasses laboratory materials and consumables, specialized equipment and instrumentation, and procurement and workflow support services. Primary offerings include high-purity chemicals, chromatography resins, fluid-handling assemblies, and implant-grade silicones serving scientific and industrial laboratories and production facilities worldwide.
The company serves over 300,000 customer locations across approximately 180 countries, maintaining more than 200 facilities globally for manufacturing, distribution, service, and research. Its infrastructure includes over 40 global manufacturing facilities, six of which are cGMP-compliant and registered with regulatory authorities, along with 15 innovation centers. Avantor employs around 13,500 people in over 30 countries. The provided text does not disclose the company's headquarters location.
Summary of the business section of Avantor's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Avantor, Inc.
- Founded
- 1904
- Headquarters
- Radnor, PA
- Address
- Radnor Corporate Center, Building One, Suite 200, 100 Matsonford Road 19087
- Phone
- (610) 386-1700
- Website
- avantorsciences.com
- Employees
- 13,500, Dec 31, 2025
- Industry
- Laboratory Analytical Instruments
- Fiscal year ends
- December 31
- Auditor
- Deloitte & Touche LLP, Philadelphia, Pennsylvania
Stock & identifiers
- Ticker
- AVTR
- Exchange
- NYSE
- IPO date
- May 20, 2019
- Shares outstanding
- 676M, Jul 24, 2026
- Public float
- $9.17B, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 1722482
- CUSIP
- 05352A100
- ISIN
- US05352A1007
- LEI
- 5493003VM0XB4U8YD238
- EIN
- 82-2758923
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Emmanuel Ligner | President and CEO, Director | 737,334 |
| Michael Stubblefield | President & CEO, Director | 1,917,522 |
| Todd W. Garner | EVP and CFO | 49,688 |
| Brittany Hankamer | EVP, Chief HR Officer | 248,864 |
| Steven W. Eck | SVP & Chief Accounting Officer | 129,593 |
| Claudius Sokenu | EVP, Chief Legal & Compliance | 251,228 |
| Corey Walker | President, VWR Dist. & Servs. | 384,535 |
| Ludovic Brellier | EVP, Bioscience & Medtech | 146,566 |
| Benoit Gourdier | EVP, Bioscience & Medtech | 362,859 |
| R. Brent Jones | EVP, Chief Financial Officer | 419,782 |
| Mary Blenn | EVP, Chief Operating Officer | 253,384 |
| Christophe Couturier | EVP, AMEA | 211,271 |
| James Bramwell | EVP Sales, Customer Excellence | 86,605 |
| Michael Severino | Director | 85,821 |
| Mala Murthy | Director | 69,479 |
| Gregory L. Summe | Director | 483,381 |
| Sanjeev K. Mehra | Director | 508,376 |
| Joseph R. Massaro | Director | 77,408 |
| Gregory T. Lucier | Director | 94,006 |
| Louise Makin | Director | 47,140 |
| Simon Dingemans | Director | 56,495 |
| Jonathan M. Peacock | Director | 219,815 |
| Juan Andres | Director | 65,480 |
| John Carethers | Director | 45,858 |
| Lan Kang | Director | 52,315 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Emmanuel Ligner | $5.90M | $6.10M | $5.38M | $41 | $148 |
| FY2025 Michael Stubblefield | $13.08M | -$1.38M | $5.38M | $41 | $148 |
| FY2024 Emmanuel Ligner | $0 | $0 | $3.43M | $116 | $147 |
| FY2024 Michael Stubblefield | $14.53M | $11.18M | $3.43M | $116 | $147 |
| FY2023 Emmanuel Ligner | $0 | $0 | $3.68M | $126 | $143 |
| FY2023 Michael Stubblefield | $12.34M | $8.93M | $3.68M | $126 | $143 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had approximately 13,500 employees located in over 30 different countries in a variety of roles.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| May 31, 2022 | Deregistration | Termination of SEC registration (Form 15) |
| May 17, 2022 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| May 16, 2022 | Delisting | Notice of delisting from exchange (Form 25) |
| May 20, 2019 | IPO | Initial public offering priced (424B4 prospectus) |
| May 13, 2019 | Listing | Registration of securities on an exchange (Form 8-A) |
| Dec 28, 2017 | Name change | Name changed from Vail Holdco Corp to Avantor, Inc. |